Joshua Michael Hare, MD
Founding Director,
Interdisciplinary Stem Cell Institute
University of Miami
Miller School of Medicine
- Time:
Cardiovascular diseases offer a compelling opportunity for regenerative and cellular therapies that can repair damaged tissue, promote vascularization, modulate inflammation, or restore cardiac function. However, translating research advances into meaningful therapeutics requires connecting a strong biological rationale with appropriate cell types, indications and therapeutic strategies, and patients who are most likely to benefit.
In this GEN webinar, our expert speaker will examine how therapeutically relevant research is helping shape the development of cell therapies for cardiovascular disease. His presentation will cover strategies for selecting indications, biological targets, and cell types based on disease pathophysiology and unmet clinical need. Attendees will also learn about the path from laboratory research to clinical investigation, including considerations around cell delivery and patient selection, and the clinical endpoints needed to evaluate safety and therapeutic benefit.
A live Q&A session will follow the presentation offering you a chance to pose questions to our expert panelist.
Produced with support from:
